6 ottobre 2025|
AI
|about 2 months agoRoche's AI Kidney Test Receives European Certification
Basel-based Roche achieves breakthrough as its artificial intelligence-powered kidney disease assessment tool gains CE marking, targeting early diagnosis for 700 million patients globally.
AI
Generated IllustrationKey Takeaways
AI
- Roche's AI-based Chronic Kidney Disease algorithm panel has received the European CE marking of conformity.
- The tool targets early diagnosis for patients with chronic kidney disease, diabetes, or hypertension.
- Roche is integrating the tool into its Navify digital platform.
- The tool is currently available in Europe and the UK, with expansion planned for the US, Middle East, and Asia.
- Roche reported 2024 revenues of CHF 60.5 billion and a net profit of CHF 9.2 billion.
By The Numbers
700 million
people affected
60.5 billion
CHF revenue
9.2 billion
CHF net profit
1896
founding year
They Said
"Chronic kidney disease affects more than 700 million people worldwide and is widely recognised as a global health challenge."
"With early diagnosis and appropriate treatment, it is possible to delay or prevent the decline in kidney function and reduce cardiovascular health risks, as well as related healthcare costs."